Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03042715 · ClinicalTrials.gov registry record
Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)
A clinical trial of Stem Cell Transplant Complications, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT03042715: Completed study of Stem Cell Transplant Complications, sponsored by Massachusetts General Hospital.
NCT03042715 is a study of Stem Cell Transplant Complications that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 185-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03042715, a study of Stem Cell Transplant Complications, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is evaluating a psychological intervention for caregivers of patients undergoing stem cell transplantation. Phase 1 will include a qualitative phase to refine the intervention to specifically target the needs of caregivers Phase 2 of the trial will transition to an interventional randomization clinical trial
Primary Outcome
qualitative data to develop and refine the caregiver intervention
Conditions Studied
Interventions
- BEHAVIORAL Qualitative Interviews
Study Locations (1)
Massachusetts
- Massachusetts general Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2017-08-01 |
What the finished NCT03042715 record still lists
NCT03042715 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 185-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Stem Cell Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which Qualitative Interviews is the first listed.
NCT03042715 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03042715 about?
NCT03042715 is a clinical study titled "Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)". This research study is evaluating a psychological intervention for caregivers of patients undergoing stem cell transplantation. Phase 1 will include a qualitative phase to refine the intervention to specifically target the needs of caregivers Phase 2 of the trial will transition to an intervention...
What is the current status of trial NCT03042715?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2017-03-06. Estimated completion is 2017-08-01.
What conditions does trial NCT03042715 study?
This clinical trial studies the following conditions: Stem Cell Transplant Complications.
What interventions are being tested in trial NCT03042715?
The interventions under investigation include: Qualitative Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT03042715?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03042715 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03042715's enrollment target sits among peer trials
6 16th of 15 the lowest of 15 other Stem Cell Transplant Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stem Cell Transplant Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
RECRUITING · Phase 2
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
RECRUITING · Phase 3
-
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
RECRUITING
-
IS-free Treg HaploHCT
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI